Search

everythinglearnresearchcommunity

for

Search:↓

Metformin is less effective in men with early-onset hair loss.

The new rodent model successfully mimics non-lean human PCOS symptoms.

High uric acid levels are more common in PCOS patients, especially those with androgenic PCOS, and are linked with increased cardiovascular risk and other metabolic issues.

Spironolactone improved symptoms in women with hormonal imbalances and had few side effects.

Dutasteride, usually used for prostate issues and hair loss, could potentially treat Amyotrophic Lateral Sclerosis (ALS) due to its neuroprotective, antioxidant, and anti-inflammatory properties, but more testing is needed.

Early hormones shape sex-specific differences in rat glands.

Artemisia sieversiana extract may help prevent hair loss and promote hair growth.

The study found that PCOS affects about 6.5-6.8% of women in both urban and rural areas of Telangana, India, and highlighted the importance of lifestyle changes for management.

Hormone testing may not be very helpful in diagnosing female pattern hair loss.

Higher androgen levels during puberty are linked to shorter adult height in boys with Silver-Russell syndrome.

Ultrasound boosts finasteride's hair growth effects in mice.

Many women with polycystic ovary syndrome have normal blood sugar, but some may have higher blood sugar levels or diabetes, especially if they are older, overweight, and have certain hormone levels.

Most cases of high male hormone levels in women are due to polycystic ovary syndrome.

Dihydrotestosterone makes arteries stiffer in female mice by reducing estrogen receptor expression.

Justicia procumbens extract may help prevent hair loss and improve hair thickness and shine in a type of hair loss condition.

New liposome treatment successfully delivers CRISPR to deactivate a key enzyme in androgen-related disorders.

Higher SHBG levels are linked to less severe hair loss in women, but vitamin D levels don't seem to affect hair loss.

Gender-affirming hormone therapy improves physical performance in trans men to the level of cisgender men, while in trans women, it increases fat mass and decreases muscle mass, with no advantage in physical performance after 2 years.

Higher levels of the protein Pannexin-1 may play a role in hair loss in women with PCOS.

Women with PCOS and hair loss have lower levels of the protein gelsolin in their blood.

The document concludes that personalized hormonal treatments are important for transgender individuals and more research is needed for non-binary treatments.

Women with Polycystic Ovary Syndrome (PCOS) have lower levels of a substance called DIAPH1 in their blood, which is linked to changes in sugar metabolism and insulin resistance.

The herbal mixture could potentially improve hair loss.

Men and women react differently to opioids, with hormones potentially influencing these differences.

All women with Polycystic Ovary Syndrome (PCOS) in a study had at least one skin disorder, with the most common being excessive hair growth, acne, dark skin patches, hair loss, and oily skin.

Using stem cells from hair follicles to treat female hair loss is safe and effective after six months.

Metformin lowers prolactin in women without PCOS but not in those with PCOS, where it reduces other hormones instead.

Androgens and SARMs play a role in body mass, frailty, skin health, and hair growth, and are used in treating prostate cancer, acne, and hair loss, with potential for new uses and improved versions in the future.

High levels of male hormones and irregular periods best predict how well PCOS patients will respond to metformin treatment.

The 2023 guideline advises a detailed approach for PCOS, focusing on early detection, lifestyle and medical treatments, and managing health risks.